Navigation Links
CPhI India and Co-Located Events Offer Diverse Programme to Support the Growing Indian Pharma Market
Date:10/18/2011

AMSTERDAM, Oct. 18, 2011 /PRNewswire/ -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced details of CPhI India and its co-located events, which will be hosted from 30th November to 2nd December, 2011 at the Bombay Exhibition Centre in Mumbai, India. Focused on pharmaceutical ingredients, CPhI India will be joined by co-located events: P-MEC India for pharmaceutical equipment, machinery and technology; ICSE India for contract services, clinical trials; and CRO and the BioPh trail for the biopharma market. Catering to all sectors in the pharma industry, both domestic and international, UBM Live's cluster of India-focused events offer attendees a dedicated platform to network with key decision makers in the Indian pharmaceutical industry, connect with existing  partners and make new contacts. In 2010 the events hosted over 26,400 visitors and over 800 exhibiting companies, figures that UBM Live expects to be exceed this year.

Continuing UBM Live's commitment to developing and evolving value-add initiatives for visitors and exhibitors around its Indian events, the CPhI India Conference Series will return in 2011. Introduced in 2010 to positive feedback, the series programme will cover a selection of key trends and topics pertinent to the Indian and South Asian pharmaceuticals markets, including: Global Clinical Trials; Global Biosimilars Regulations; Healthcare and OTC Drugs; Developing Difficult Generics; Export Potential; and Competitive API Strategies.  The conference series will feature high level speakers from respected companies such as Sanofi-Aventis, GlaxoSmithKline, Pfizer, and Dr. Reddy's Laboratories.

"Mirroring the increasing importance of the Indian pharmaceutical market, CPhI India and co-located events have been built around a unique programme based on consultation and feedback from visitors and exhibitors," commented Annemieke Timmers, Brand Director CPhI. "We have geared the show to deliver significant return on investment (ROI) for pharma professionals who are currently working with or looking to establish relationships with Indian pharmaceutical companies.  Our events offer direct access to a high-growth market that is estimated to generate US $13.1 Billion revenue in FY 2011(1). Beyond the immediate projections for the market, the domestic pharmaceutical industry in India is expected to further grow at a compounded annual growth rate (CAGR) of around 15% during FY 2012-FY 2014(2).  Our visitors are guaranteed to benefit from strengthening current business relations and making new business connections in a market that is well equipped to scale-up to requests for products and services quickly through networks that take advantage of the latest technologies available."

CPhI India and P-MEC India are the largest and most comprehensive pharma industry events in South Asia and have gained a reputation as the 'must attend' events in this market. Additionally, ICSE India has quickly gained a positive reputation in the market by offering direct access to the outsourcing and contract services sector which is one of the fastest growing segments within the Indian pharmaceutical industry, and weekly pre-registrations are currently running over 300% higher than they were at the same time in 2010.

UBM Live's market leading annual schedule of pharma brands includes CPhI for pharmaceutical ingredients, ICSE for contract services and outsourcing, P-MEC Europe for pharmaceutical equipment, machinery and technology, InnoPack for innovative packaging concepts in the pharmaceutical packaging market, and BioPh for the biopharmaceuticals market. Co-located annual events include Worldwide (25-27, October, Messe Frankfurt, Germany 2011), Japan (21-23 March, 2012, Tokyo Big Sight Exhibition Center, Japan) China (26-28 June, 2012, SNIEC, Shanghai, China), and South America (21-23 August, 2012, Transamerica Expo Centre, Brazil).

(1) RNCOS, India Pharma Sector Forecast 2014

(2) RNCOS, India Pharma Industry Set to Take Off in Near Future

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to www.ubmlive.com.


'/>"/>
SOURCE UBM Live
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
2. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
3. Neutropenia: Biosimilar Product from India Moves One Step Closer to European Market
4. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
5. International Diabetes Federation Grant Supports Lifestyle Intervention Study to Prevent Type 2 Diabetes in India
6. Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks
7. Patient Recruitment Begins in India for Phase 3 Diabetes Trial
8. Report on 300 New Medicines in Development for Heart Disease and Stroke Released in Indianapolis
9. Life Sciences Company Opens Clinical Trial Bridge to India
10. Pioneering Brain Malformation Treatment Performed Using Novalis Tx(TM) Radiosurgery Technology in India
11. Reportlinker Adds Medical Devices & Equipment in India (2009)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... FOSTER CITY, Calif. , Feb. 4, 2016 ... (the "Company") today announced it has entered into ... and Exchange Commission (SEC) fully resolving the SEC,s ... Practices Act (FCPA).  Under the terms of the ... total of $12.8 million, including disgorgement, pre-judgment interest ...
(Date:2/4/2016)... Feb. 4, 2016 Frontier Pharma: Chronic ... First-in-Class Innovation Chronic Obstructive Pulmonary ... chronic inflammation of the airways and lungs. Persistent ... make the disease one of the leading causes ... in the world. COPD is linked to cumulative ...
(Date:2/4/2016)... 2016  AMRI (NASDAQ:  AMRI) today announced that Anthony ... President of Pfizer Global Supply, has been elected to the ... In addition, the Company announced that Mr. Gabe Leung ... 2010, has retired from the AMRI Board of Directors in ... business ventures.  William S. Marth , President ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... 05, 2016 , ... Love is in the air at King Kullen! The ... and packaging. This staple for Valentine’s Day is a must-have, and can be picked ... Day, not only are long-stem roses available, but also other flower bouquets, elegantly wrapped ...
(Date:2/5/2016)... ... 05, 2016 , ... The event is being held on April 7, 2016 ... Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research for the care and ... Parkinson’s disease and is the architect of this informative event to raise awareness and ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... George H. Van Allen have signed a joint enrollment and degree completion agreement. ... pathway toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... independent PROSHRED franchises from across the country gathered at the La Valencia Hotel ... top performers. PROSHRED Chicago was named the year’s most outstanding franchise, walking ...
(Date:2/5/2016)... SARASOTA, Fla., (PRWEB) , ... February 05, 2016 , ... ... appetizing recipes just in time for this weekend’s Big Game. Take the stress out ... ingredients that will keep your guests happy at every stage of the game. , ...
Breaking Medicine News(10 mins):